SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A.H. Shikani, K. Kourelis, M.A. Alqudah, H.J. Shikani, E. Cope, N. Kirk, D. Bergstedt, R.J. Basaraba, J.G. Leid, Multimodality topical therapy for refractory chronic rhinosinusitis: Our experience in thirteen patients with and twelve patients without nasal polyps, Clinical Otolaryngology, 2013, 38, 3
  2. 2
    Luke Rudmik, Monica Hoy, Rodney J. Schlosser, Richard J. Harvey, Kevin C. Welch, Valerie Lund, Timothy L. Smith, Topical therapies in the management of chronic rhinosinusitis: an evidence-based review with recommendations, International Forum of Allergy & Rhinology, 2013, 3, 4
  3. 3
    Richard D deShazo, Scott P Stringer, Atrophic rhinosinusitis: progress toward explanation of an unsolved medical mystery, Current Opinion in Allergy and Clinical Immunology, 2011, 11, 1, 1

    CrossRef

  4. 4
    Russell A. Settipane, Other Causes of Rhinitis: Mixed Rhinitis, Rhinitis Medicamentosa, Hormonal Rhinitis, Rhinitis of the Elderly, and Gustatory Rhinitis, Immunology and Allergy Clinics of North America, 2011, 31, 3, 457

    CrossRef

  5. You have free access to this content5
    G. K. Scadding, S. R. Durham, R. Mirakian, N. S. Jones, A. B. Drake-Lee, D. Ryan, T. A. Dixon, P. A. J. Huber, S. M. Nasser, BSACI guidelines for the management of rhinosinusitis and nasal polyposis, Clinical & Experimental Allergy, 2008, 38, 2
  6. 6
    Kien R. Ha, Alkis J. Psaltis, Andrew R. Butcher, Peter-John Wormald, Lor Wai Tan, In Vitro Activity of Mupirocin on Clinical Isolates of Staphylococcus aureus and its Potential Implications in Chronic Rhinosinusitis, The Laryngoscope, 2008, 118, 3
  7. 7
    Brent Uren, Alkis Psaltis, Peter-John Wormald, Nasal Lavage With Mupirocin for the Treatment of Surgically Recalcitrant Chronic Rhinosinusitis, The Laryngoscope, 2008, 118, 9
  8. 8
    C. Arturo Solares, Pete S. Batra, Geraldine S. Hall, Martin J. Citardi, Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations, American Journal of Otolaryngology, 2006, 27, 3, 161

    CrossRef

  9. 9
    W. Fokkens, V. Lund, C. Bachert, P. Clement, P. Helllings, M. Holmstrom, N. Jones, L. Kalogjera, D. Kennedy, M. Kowalski, H. Malmberg, J. Mullol, D. Passali, H. Stammberger, P. Stierna, EAACI Position Paper on Rhinosinusitis and Nasal Polyps Executive Summary, Allergy, 2005, 60, 5
  10. 10
    Valerie J. Lund, Maximal Medical Therapy for Chronic Rhinosinusitis, Otolaryngologic Clinics of North America, 2005, 38, 6, 1301

    CrossRef

  11. 11
    Timothy R. Miller, Harlan R. Muntz, M Erik Gilbert, Richard R. Orlandi, Comparison of Topical Medication Delivery Systems after Sinus Surgery, The Laryngoscope, 2004, 114, 2
  12. 12
    Winston C. Vaughan, Nebulization of antibiotics in management of sinusitis, Current Infectious Disease Reports, 2004, 6, 3, 187

    CrossRef

  13. 13
    Neil Bhattacharyya, Jo Shapiro, Contemporary trends in microbiology and antibiotic resistance in otolaryngology, Auris Nasus Larynx, 2002, 29, 1, 59

    CrossRef

  14. 14
    Michelle M. Cullen, William E. Bolger, Maximal medical management of chronic rhinosinusitis, Current Opinion in Otolaryngology & Head and Neck Surgery, 2000, 8, 1, 7

    CrossRef

  15. 15
    Robin Youngs, Sinusitis in adults, Current Opinion in Pulmonary Medicine, 2000, 6, 3, 217

    CrossRef

  16. You have free access to this content16
    Yau Hong Goh, Richard L. Goode, State of the Art Review: Current Status of Topical Nasal Antimicrobial Agents, The Laryngoscope, 2000, 110, 6